About Oddzial Chorob Wewnetrznych i Hematologii
Clinical Trials at Oddzial Chorob Wewnetrznych i Hematologii
During the past decade, Oddzial Chorob Wewnetrznych i Hematologii conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Oddzial Chorob Wewnetrznych i Hematologii
According to Clinical.Site data, the most researched conditions in "Oddzial Chorob Wewnetrznych i Hematologii" are
"Lymphoma, T-Cell, Cutaneous" (2 trials), "Mycosis Fungoides" (2 trials) and "Sezary Syndrome" (2 trials). Many other conditions were trialed in "Oddzial Chorob Wewnetrznych i Hematologii" in a lesser frequency.
Clinical Trials Intervention Types at Oddzial Chorob Wewnetrznych i Hematologii
Most popular intervention types in "Oddzial Chorob Wewnetrznych i Hematologii" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ONTAK" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Oddzial Chorob Wewnetrznych i Hematologii
The vast majority of trials in "Oddzial Chorob Wewnetrznych i Hematologii" are
2 trials for "All" genders.
Clinical Trials Status at Oddzial Chorob Wewnetrznych i Hematologii
Currently, there are NaN active trials in "Oddzial Chorob Wewnetrznych i Hematologii".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Oddzial Chorob Wewnetrznych i Hematologii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oddzial Chorob Wewnetrznych i Hematologii, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".